Previous Article | Next Article ![]()
Journal of Virology, February 2003, p. 2753-2756, Vol. 77, No. 4
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.4.2753-2756.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Simon Chowdhury,1 Stuart J. Neil,1 Kerry A. Chester,2 Francois-Loic Cosset,3 and Mary K. Collins1*
Department of Immunology and Molecular Pathology, Windeyer Institute,1 CRC Targeting and Imaging Group, Department of Oncology, Royal Free and University College Medical School, London, United Kingdom,2 Laboratoire Vectorologie Retrovirale et Therapie Genique, Unite de Virologie, Humaine, U412 INSERM, IFR 74 and ENS de Lyon, France3
Received 23 July 2002/ Accepted 14 November 2002
Retroviruses expressing two different receptor-binding domains linked by proline-rich spacers infect only cells expressing both retroviral receptors (Valsesia-Wittman et al., EMBO J. 6:1214-1223, 1997). Here we apply this receptor cooperation strategy to target human tumor cells by linking single-chain antibodies recognizing tumor antigens via proline-rich spacers to the 4070A murine leukemia virus surface protein.
Present address: Unidad Mixta de Investigaciones Médicas, Hospital Clínico San Cecilio, Granada, Spain.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|